POSTPARTUM CARDIAC ARRHYTHMIAS

SCF ENCYCLOPEDIA ENTRY

SCF-RDOS INDICATION REGISTRY

POSTPARTUM CARDIAC ARRHYTHMIAS

SCF-RDOS Registry Code: SCF-RDOS-PPD-CV-003

ICD Alignment: Cardiac Arrhythmias Complicating Pregnancy, Childbirth, and the Postpartum Period

SCF Classification: Postpartum Cardiovascular Disease

SCF Disease Domain: Maternal Cardiac Electrophysiological Dysregulation Syndrome

SCF Pathogenesis Tier: Tier III–VI Neurocardiac-Electrophysiologic Failure Disorder

Clinical Category: Postpartum Rhythm and Conduction Disorders

SCF Clinical Priority Level: Moderate to Critical (Subtype Dependent)

FDA Therapeutic Area: Cardiovascular Disease / Electrophysiology

⸻

1. DEFINITION

Postpartum Cardiac Arrhythmias comprise a spectrum of abnormal cardiac rhythm disorders occurring during the puerperium and postpartum period due to alterations in:

Cardiac electrophysiology
Neurohormonal signaling
Autonomic nervous system regulation
Electrolyte homeostasis
Myocardial structure
Inflammatory pathways

Arrhythmias may be:

Benign
Symptomatic
Hemodynamically unstable
Potentially fatal

Within the SCF framework, Postpartum Cardiac Arrhythmias represent:

A neurocardio-immunometabolic desynchronization disorder characterized by disruption of myocardial electrical coherence resulting from postpartum physiological, inflammatory, hormonal, metabolic, and structural perturbations.

⸻

2. SCF ETIOPATHOGENIC CORE

Primary Disease Drivers

Electrophysiologic Instability

Abnormalities involving:

SA node automaticity
AV nodal conduction
Ventricular conduction systems
Repolarization pathways

⸻

Neurohormonal Changes

Postpartum fluctuations in:

Estrogen
Progesterone
Prolactin
Catecholamines

Result:

Electrical instability
Altered autonomic tone

⸻

Autonomic Dysregulation

Characterized by:

Sympathetic overactivation
Reduced vagal tone
Heart rate variability impairment

⸻

Structural Cardiac Remodeling

Associated with:

Peripartum cardiomyopathy
Myocarditis
Ventricular dilation
Fibrosis

⸻

Metabolic Dysfunction

Contributors include:

ATP depletion
Mitochondrial dysfunction
Oxidative stress
Electrolyte abnormalities

⸻

3. SCF FAULT ARCHITECTURE

SCF Fault Node	Functional Failure
Electrophysiologic Desynchronization Node	Abnormal impulse generation
Conduction Failure Node	Delayed or blocked impulse propagation
ATP Collapse Node	Impaired ion channel function
Mitochondrial Failure Node	Reduced electrical stability
Neurohormonal Hyperactivation Node	Sympathetic excess
Immune Desynchronization Node	Myocardial inflammatory injury
ECM Remodeling Node	Electrical conduction heterogeneity
Connectomic Dysregulation Node	Autonomic imbalance

⸻

4. CLINICAL SUBTYPE REGISTRY

SCF-RDOS-PPD-CV-003A

Sinus Tachycardia Syndrome

Features:

Persistent heart rate elevation
Palpitations
Exercise intolerance

⸻

SCF-RDOS-PPD-CV-003B

Inappropriate Sinus Tachycardia

Characterized by:

Elevated resting heart rate
Autonomic dysregulation
Exaggerated sympathetic tone

⸻

SCF-RDOS-PPD-CV-003C

Premature Atrial Contractions (PACs)

Manifestations:

Palpitations
Irregular heartbeat sensation

⸻

SCF-RDOS-PPD-CV-003D

Premature Ventricular Contractions (PVCs)

Manifestations:

Skipped beats
Ventricular ectopy
Symptomatic palpitations

⸻

SCF-RDOS-PPD-CV-003E

Supraventricular Tachycardia (SVT)

Includes:

AVNRT
AVRT
Focal atrial tachycardia

⸻

SCF-RDOS-PPD-CV-003F

Atrial Fibrillation

Characteristics:

Irregularly irregular rhythm
Thromboembolic risk
Hemodynamic compromise

⸻

SCF-RDOS-PPD-CV-003G

Atrial Flutter

Features:

Organized atrial reentry circuits
Rapid atrial rates

⸻

SCF-RDOS-PPD-CV-003H

Ventricular Tachycardia

Potential causes:

Cardiomyopathy
Myocarditis
Structural heart disease

⸻

SCF-RDOS-PPD-CV-003I

Ventricular Fibrillation

Life-threatening emergency characterized by:

Loss of effective cardiac output
Sudden cardiac arrest

⸻

SCF-RDOS-PPD-CV-003J

Long QT Syndrome Exacerbation

Postpartum period is associated with:

Increased arrhythmic risk
Torsades de Pointes susceptibility

⸻

SCF-RDOS-PPD-CV-003K

Torsades de Pointes

Associated with:

QT prolongation
Electrolyte abnormalities
Drug interactions

⸻

SCF-RDOS-PPD-CV-003L

Bradyarrhythmias

Includes:

Sinus node dysfunction
Junctional rhythms

⸻

SCF-RDOS-PPD-CV-003M

Atrioventricular Block

Includes:

First-degree AV block
Second-degree AV block
Complete heart block

⸻

5. MOLECULAR MULTI-OMICS PATHOGENESIS MAP

Genomics

Genes implicated in susceptibility:

Ion Channel Genes

KCNQ1
KCNH2
SCN5A
KCNE1
KCNE2

Structural Genes

TTN
LMNA
DSP
FLNC

⸻

Transcriptomics

Upregulated pathways:

TNF-α
IL-6
NF-κB
Adrenergic signaling

Downregulated:

Mitochondrial energy pathways
Gap junction maintenance pathways

⸻

Proteomics

Abnormalities involve:

Connexin proteins
Ion channel proteins
Sarcomeric proteins

Result:

Electrical instability
Conduction heterogeneity

⸻

Metabolomics

Characteristic findings:

ATP depletion
Magnesium deficiency
Potassium imbalance
Oxidative stress metabolites

⸻

Epigenomics

Potential contributors:

Hormonal reprogramming
Inflammatory transcriptional shifts

⸻

Interactomics

Disrupted pathways:

Calcium signaling
Sodium channel regulation
Potassium channel regulation
Adrenergic signaling

⸻

Connectomics

Major abnormalities:

Sympathetic dominance
Reduced parasympathetic regulation
Heart-brain signaling dysregulation

⸻

Biomechanicalomics

Structural contributors:

Ventricular dilation
Fibrosis
Myocardial stretch
Altered conduction geometry

⸻

6. SCF PATHOGENESIS FLOW

Stage 1 — Postpartum Physiologic Transition

Hormonal withdrawal

↓

Hemodynamic redistribution

↓

Autonomic instability

↓

Stage 2 — Electrophysiologic Vulnerability

Ion channel dysfunction

↓

Altered repolarization

↓

Electrical instability

↓

Stage 3 — Trigger Generation

Electrolyte shifts

Inflammation

Structural remodeling

↓

Stage 4 — Arrhythmogenic Circuit Formation

Triggered activity

↓

Reentry pathways

↓

Abnormal automaticity

↓

Stage 5 — Clinical Arrhythmia

Palpitations

↓

Tachyarrhythmia

Bradyarrhythmia

↓

Stage 6 — Hemodynamic Consequences

Reduced cardiac output

↓

Syncope

↓

Heart failure

↓

Cardiac arrest

⸻

7. CLINICAL PRESENTATION

Mild Disease

Palpitations
Awareness of heartbeat
Anxiety-like symptoms
Exercise intolerance

⸻

Moderate Disease

Dizziness
Presyncope
Dyspnea
Chest discomfort

⸻

Severe Disease

Syncope
Heart failure
Cardiogenic shock
Sudden cardiac arrest

⸻

8. DIAGNOSTIC BIOMARKERS

Electrophysiologic Evaluation

Electrocardiogram

Assess:

Rhythm
QT interval
Conduction abnormalities

⸻

Holter Monitoring

Detect:

Episodic arrhythmias
Frequency burden
Heart rate variability

⸻

Event Monitoring

For intermittent symptoms.

⸻

Laboratory Biomarkers

Evaluate:

BNP
NT-proBNP
Troponin
Potassium
Magnesium
Calcium
Thyroid function

⸻

Imaging

Echocardiography

Evaluate:

Structural abnormalities
Ventricular function
Peripartum cardiomyopathy

⸻

Cardiac MRI

Assess:

Fibrosis
Myocarditis
Structural substrates

⸻

9. SCF THERAPEUTIC MECHANISMS

A. SCF-PCR PREVENTATIVE MODULE

Objectives

Reduce arrhythmogenic vulnerability.

Targets:

Electrolyte stability
Autonomic regulation
Mitochondrial function

⸻

B. SCF-PCR CURATIVE MODULE

Objectives

Suppress active arrhythmias.

Targets:

Reentry circuits
Triggered activity
Conduction abnormalities

Interventions may include:

Antiarrhythmic pharmacotherapy
Rate control
Rhythm control
Electrophysiologic procedures

⸻

C. SCF-PCR RESTORATIVE MODULE

Objectives

Restore long-term electrophysiologic coherence.

Targets:

Mitochondrial recovery
Fibrosis reduction
Neurocardiac synchronization
Structural remodeling reversal

⸻

10. RESISTANCE & OFF-TARGET MODELING

Failure Node	Consequence
Persistent fibrosis	Recurrent arrhythmias
Ongoing inflammation	Electrical instability
Sympathetic overactivation	Tachyarrhythmia recurrence
Cardiomyopathy progression	Ventricular arrhythmias
Ion channel dysfunction	Sudden cardiac death risk

⸻

11. PROGNOSTIC STRATIFICATION

Low Risk

Isolated PACs/PVCs
Normal cardiac structure
No syncope

⸻

Intermediate Risk

SVT
Atrial fibrillation
Mild ventricular dysfunction

⸻

High Risk

Ventricular tachycardia
Long QT syndrome
Torsades de Pointes
Ventricular fibrillation
Peripartum cardiomyopathy-associated arrhythmias

⸻

12. SCF THERAPEUTIC TARGET MAP

Target	SCF Function
Sodium channels	Conduction stabilization
Potassium channels	Repolarization control
Calcium channels	Electrical regulation
Connexins	Gap junction integrity
TNF-α	Inflammation control
IL-6	Immune modulation
Mitochondria	ATP restoration
Sympathetic pathways	Autonomic stabilization
Fibrotic pathways	Conduction preservation
RAAS	Structural remodeling control

⸻

13. PROJECT RHENOVA INTEGRATION PATHWAYS

RHENOVA-CARDIO-ARRHYTHMIA

Module A

Maternal electrophysiologic instability atlas.

Module B

Postpartum autonomic dysfunction mapping.

Module C

Neurocardiac connectomic analysis.

Module D

Arrhythmogenic fibrosis modeling.

Module E

Precision postpartum electrophysiology therapeutics.

⸻

14. NEXT STRATEGIC RESEARCH PATHWAYS

Priority 1

Multi-omic postpartum arrhythmia atlas.

Priority 2

Neurocardiac autonomic biomarker panels.

Priority 3

Mitochondrial-electrophysiologic restoration platforms.

Priority 4

AI-guided sudden cardiac death prediction systems.

Priority 5

SCF-derived antiarrhythmic API discovery program.

⸻

SCF-RDOS INDICATION SUMMARY

Parameter	Classification
Disease	Postpartum Cardiac Arrhythmias
Registry Code	SCF-RDOS-PPD-CV-003
Disease Domain	Cardiovascular
SCF Fault Tier	III–VI
Primary Systems	Cardiac, Neural, Immune, Metabolic
Principal Fault Nodes	Electrophysiologic Desynchronization, ATP Collapse, Neurohormonal Hyperactivation
Mortality Risk	Variable to Critical
Therapeutic Priority	High
SCF-PCR Applicability	Preventative, Curative, Restorative

⸻

MASTER REGISTRY INDEX

SCF-RDOS-PPD-CV-003 — Postpartum Cardiac Arrhythmias

SCF-RDOS-PPD-CV-001 — Peripartum Cardiomyopathy

SCF-RDOS-PPD-CV-002 — Postpartum Heart Failure

SCF-PATH-0001 — SCF Pathophysiology Protocol (Universal Template)

SCF-SEF-MD-0001 — SCF Synergistic Evaluation Framework

SCF-CRD-WORKFLOW-0001 — SCF Clinical Research & Development Workflow

SCF-API-DP-0001 — SCF API Discovery Profile

SCF-RDOS-PPD-0001 — Postpartum Disorders & Diseases Registry

SCF-ENC-IND-CV-0003 — SCF Encyclopedia Entry Series: Postpartum Cardiovascular Disorders